Kiniksa Pharmaceuticals International, plc
KNSA
Classificação em ações
#2982
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company,... Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
Preço da ação
$79.07
Valor de mercado
$6.17B
Variação (1 dia)
0.61%
Variação (1 ano)
104.63%
País
GB
Negociar Kiniksa Pharmaceuticals International, plc (KNSA)
Categoria
Healthcare
EPS de Kiniksa Pharmaceuticals International, plc (KNSA)
EPS em June 2026 TTM: $1.07
De acordo com os últimos relatórios financeiros e o preço das ações da Kiniksa Pharmaceuticals International, plc, o EPS atual da empresa (TTM) é $1.07. No final de 2023, a empresa teve um EPS de $0.20, uma diminuição em relação a ao EPS de 2022, que foi de $2.64.
Histórico de EPS da Kiniksa Pharmaceuticals International, plc de 2016 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2026 (TTM) | $1.07 | -278.33% |
| 2024 | $-0.60 | -400.00% |
| 2023 | $0.20 | -92.42% |
| 2022 | $2.64 | -214.78% |
| 2021 | $-2.30 | -11.88% |
| 2020 | $-2.61 | -12.71% |
| 2019 | $-2.99 | -14.33% |
| 2018 | $-3.49 | 74.50% |
| 2017 | $-2.00 | 170.27% |
| 2016 | $-0.74 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| $2.41 | 125.23% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $0.52 | -51.40% |
US
|
